We also found that female dialysis patients were more likely to have higher adiponectin concentrations vs. their male counterparts; these observations are consistent with experimental models and human non-CKD studies in which testosterone reduces adiponectin levels [46,47]. This evidence concerns the gene ADIPOQ and chronic kidney disease.